Stay updated on Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial
Sign up to get notified when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.

Latest updates to the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 to the Record History; removed the funding-status notice and the previous Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a government funding lapse notice and release version v3.4.1. Removed release version v3.4.0.SummaryDifference0.8%

- Check28 days agoChange Detected- The Record History page now displays a Show glossary option and uses color-coded diffs (green for additions, red for deletions). It also shows a revision tag of v3.4.0, replacing the previous v3.3.4 tag.SummaryDifference1%

- Check42 days agoChange DetectedThe history shows an added Revision: v3.3.4 and a removal of Revision: v3.3.3 as part of the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 to the study record versions. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.2%

- Check92 days agoChange DetectedThis update changes only the revision history: a new Revision v3.3.2 was added and Revision v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.